Abstract
Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Current Bioactive Compounds
Title: Photosensitizer Nanoparticles for Photodynamic Therapy
Volume: 3 Issue: 4
Author(s): Toru Oba
Affiliation:
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Abstract: Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Export Options
About this article
Cite this article as:
Oba Toru, Photosensitizer Nanoparticles for Photodynamic Therapy, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220248
DOI https://dx.doi.org/10.2174/157340707783220248 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Claudin-5 Overexpression on the Interactions of Claudin-1 and -2 and Barrier Function in Retinal Cells
Current Molecular Medicine Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNAs: Modulators of Cell Identity, and their Applications in Tissue Engineering
MicroRNA Targeting Phospholipase D-mediated Survival Signals in Cancer
Current Signal Transduction Therapy Interventional Radiology in Paediatrics
Current Pediatric Reviews The Different Roles of The Channel-Kinases TRPM6 and TRPM7
Current Medicinal Chemistry High-Risk HPV/ErbB-2 Interaction on E-Cadherin/Catenin Regulation in Human Carcinogenesis
Current Pharmaceutical Design Selectively Replicating Adenoviruses for Oncolytic Therapy
Current Cancer Drug Targets The Immunohistochemical Assessment of HPV Related Adenocarcinoma: Pathologic and Clinical Prognostic Significance
Current Pharmaceutical Design Atoh1: Landscape for Inner Ear Cell Regeneration
Current Gene Therapy Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Cystine Dimethyl Ester Induces Apoptosis Through Regulation of PKC-δ and PKC-ε in Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Chalcones Derivatives Acting as Cell Cycle Blockers: Potential Anti Cancer Drugs?
Current Drug Targets The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics Natural Products Targeting Cancer Stem Cells: A Revisit
Current Medicinal Chemistry MicroRNAs in Cancer Gene Therapy: Another Look
Current Cancer Therapy Reviews Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Role of Polyamines in Breast Cancer Growth, Development and Progression
Current Cancer Therapy Reviews Targeted Therapies in Lung Cancers: Current Landscape and Future Prospects
Recent Patents on Anti-Cancer Drug Discovery Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Current Cancer Drug Targets